Diabetes mellitus is a strong independent predictor of recurrent ischemic events and mortality across the spectrum of acute coronary syndromes.
No takes yet. Share an insight, caveat, or question.
May warrant intensified secondary prevention in diabetic ACS patients; confirms predictor role across spectrum but leaves targeted trials open.
Ferreiro et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: